Enhancing Corporate Value Through Equity Compensation and Sharing Value With Shareholders
First written in FY2017. 16 of 19 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2027-H1.
105 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Resolution date: 22 May 2026. Categories and numbers of eligible persons (people): Directors of the Company, 2; full-time directors of wholly owned subsidiaries, 12; executive officers of the Company, 5. Number of stock acquisition rights (rights): ※ 225 (Note 1). Class, content and number of shares underlying the stock acquisition rights (shares): ※ Common shares, 22,500 (Note 1).」
For the stock-based compensation stock options, stock acquisition rights covering 225 rights and 22,500 shares were granted to directors, full-time directors of subsidiaries and executive officers pursuant to the resolution dated 22 May 2026. - FY2026-H1AdvancedAnnual report
「Date of resolution: 23 May 2025 / Categories and number of grantees (people): Company directors: 3; full-time directors of wholly owned subsidiaries: 14; Company executive officers: 5 / Number of stock acquisition rights (rights): * 330 (Note 1) / Class, details and number of shares underlying the stock acquisition rights (shares): * common shares, 33,000 (Note 1)」
For the stock options as share-based compensation resolved on 23 May 2025, 330 stock acquisition rights covering 33,000 common shares were granted. - FY2025-H1AdvancedAnnual report
「Date of resolution: 24 May 2024 / Categories and number of grantees (people): Company directors: 2; full-time directors of wholly owned subsidiaries: 13; Company executive officers: 5 / Number of stock acquisition rights (rights): * 536 (Note 1) / Class, details and number of shares underlying the stock acquisition rights (shares): * common shares, 53,600 (Note 1)」
For the stock options as share-based compensation resolved on 24 May 2024, 536 stock acquisition rights covering 53,600 shares were granted to directors, full-time directors of subsidiaries and executive officers. - FY2024AdvancedAnnual report
「The decrease of 49,230 treasury shares comprised the disposal of 16,900 shares as restricted stock compensation pursuant to the Board of Directors' resolution dated 19 May 2023, a decrease of 32,300 shares resulting from the exercise of stock acquisition rights, and a decrease of 30 shares resulting from requests to purchase additional odd-lot shares.」
For the share-based compensation scheme, the disposal of 16,900 restricted shares and the exercise of stock acquisition rights covering 32,300 shares were reported as results. - FY2024-Q2AdvancedAnnual report
「Date of resolution: 19 May 2023 / Categories and number of grantees (people): Company directors: 5; full-time directors of wholly owned subsidiaries: 8 / Number of stock acquisition rights (rights): * 223 (Note 1) / Class, details and number of shares underlying the stock acquisition rights (shares): * common shares, 22,300 (Note 1) / Exercise period for the stock acquisition rights: * 19 June 2023 to 18 June 2053」
For the stock options as share-based compensation resolved on 19 May 2023, 223 stock acquisition rights covering 22,300 common shares were granted. - FY2023AdvancedAnnual report
「For the resolution dated 20 May 2022, 457 stock acquisition rights covering 45,700 common shares were granted to 5 Company directors and 9 full-time directors of wholly owned subsidiaries.」
For the stock options as share-based compensation, 457 rights covering 45,700 shares were disclosed for the resolution dated 20 May 2022, and 30,700 shares were exercised during the fiscal year. - FY2023-Q2AdvancedAnnual report
「Date of resolution: 20 May 2022 / Categories and number of grantees (people): Company directors: 5; full-time directors of wholly owned subsidiaries: 9 / Number of stock acquisition rights (rights): * 457 (Note 1) / Class, details and number of shares underlying the stock acquisition rights (shares): * common shares, 45,700 (Note 1) / Exercise period for the stock acquisition rights: * 13 June 2022 to 12 June 2052」
For the stock options as share-based compensation resolved on 20 May 2022, 457 stock acquisition rights covering 45,700 shares were granted. - FY2022AdvancedAnnual report
「The decrease of 49,090 treasury shares comprised the disposal of 22,100 shares as restricted stock compensation pursuant to the Board of Directors' resolution dated 21 May 2021, a decrease of 26,900 shares resulting from the exercise of stock acquisition rights, and a decrease of 90 shares resulting from requests to purchase additional odd-lot shares.」
For the share-based compensation scheme, the disposal of 22,100 restricted shares and the exercise of stock acquisition rights covering 26,900 shares were reported as results for the fiscal year. - FY2021AdvancedAnnual report
「The decrease of 55,900 treasury shares comprised the disposal of 26,000 shares as restricted stock compensation pursuant to the Board of Directors' resolution dated 20 May 2020, and a decrease of 29,900 shares resulting from the exercise of stock acquisition rights.」
The results of the share-based compensation scheme included the disposal of 26,000 restricted shares and the exercise of stock acquisition rights covering 29,900 shares. - FY2021-Q2AdvancedAnnual report
「Date of resolution: 20 May 2020 / Categories and number of grantees (people): Company directors: 5; full-time directors of wholly owned subsidiaries: 14 / Number of stock acquisition rights (rights): * 536 (Note 1) / Class, details and number of shares underlying the stock acquisition rights (shares): * common shares, 53,600 (Note 1) / Exercise period for the stock acquisition rights: * 8 June 2020 to 7 June 2050」
For the resolution dated 20 May 2020, 536 stock acquisition rights covering 53,600 shares were granted to directors and others. - FY2020-Q2AdvancedAnnual report
「Date of resolution: 24 May 2019 / Categories and number of grantees (people): Company directors: 5; full-time directors of wholly owned subsidiaries: 14 / Number of stock acquisition rights (rights): 575 (Note 1) / Class, details and number of shares underlying the stock acquisition rights (shares): common shares, 57,500 (Note 1) / Exercise period for the stock acquisition rights: 10 June 2019 to 9 June 2049」
For the stock options as share-based compensation resolved on 24 May 2019, 575 stock acquisition rights covering 57,500 shares were granted. - FY2019-Q2AdvancedAnnual report
「Date of resolution: 21 May 2018 / Number of stock acquisition rights: 434 (Note 1) / Number of shares underlying the stock acquisition rights: 43,400 shares (Note 1)」
For the stock options as share-based compensation resolved on 21 May 2018, 434 stock acquisition rights covering 43,400 shares were issued. - FY2018-Q3RestatedAnnual report
「In addition, performance-linked restricted stock compensation and stock options as share-based compensation were introduced for directors, excluding outside directors and part-time directors, with the aim of achieving management that is even more focused on improving performance and corporate value over the medium to long term.」
The policy of introducing performance-linked restricted stock compensation and stock options as share-based compensation was reaffirmed. - FY2018-Q1AdvancedAnnual report
「As a new compensation scheme, this scheme is designed to strengthen the linkage between compensation for Eligible Directors and others and the Company's share price, and to achieve management that is even more focused on improving performance and corporate value over the medium to long term by sharing with shareholders not only the benefits of a rising share price but also the risks of a decline.」
In addition to restricted stock compensation, stock options as share-based compensation were introduced, and 614 stock acquisition rights covering 61,400 shares were allotted. Restricted shares totalled 239,000, with a three-year transfer restriction period. - FY2017First statedAnnual report
「This scheme is designed for the Company's directors, excluding outside directors and part-time directors (hereinafter, the "Eligible Directors"), to provide incentives for the sustained enhancement of corporate value and further promote value sharing with shareholders.」
A restricted stock compensation scheme was introduced for a three-fiscal-year period to provide incentives for enhancing corporate value and promote value sharing with shareholders.